Coronavirus Latest News

Coronavirus: Third jab boosts Omicron antibodies ‘significantly’, AstraZeneca study finds

British pharmaceutical giant AstraZeneca said Thursday that a third, or “booster”, dose of its Covid-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study.“Vaxzevria significantly boosted levels of antibodies against the Omicron Sars-CoV-2 variant (B. 1.1.529) following a third dose booster,” the company announced in a statement citing the study.“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly…

Read the original article at South China Morning Post

Related Articles

Back to top button